{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:15:16Z","timestamp":1780636516417,"version":"3.54.1"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Breast cancer (BRCA) is regarded as a lethal and aggressive cancer with increasing morbidity and mortality worldwide. cGAS-STING signaling regulates the crosstalk between tumor cells and immune cells in the tumor microenvironment (TME), emerging as an important DNA-damage mechanism. However, cGAS-STING-related genes (CSRGs) have rarely been investigated for their prognostic value in breast cancer patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Our study aimed to construct a risk model to predict the survival and prognosis of breast cancer patients. We obtained 1087 breast cancer samples and 179 normal breast tissue samples from the Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEX) database, 35 immune-related differentially expression genes (DEGs) from cGAS-STING-related genes were systematically assessed. The Cox regression was applied for further selection, and 11 prognostic-related DEGs were used to develop a machine learning-based risk assessment and prognostic model.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We successfully developed a risk model to predict the prognostic value of breast cancer patients and its performance acquired effective validation. The results derived from Kaplan-Meier analysis revealed that the low-risk score patients had better overall survival (OS). The nomogram that integrated the risk score and clinical information was established and had good validity in predicting the overall survival of breast cancer patients. Significant correlations were observed between the risk score and tumor-infiltrating immune cells, immune checkpoints and the response to immunotherapy. The cGAS-STING-related genes risk score was also relevant to a series of clinic prognostic indicators such as tumor staging, molecular subtype, tumor recurrence, and drug therapeutic sensibility in breast cancer patients.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> cGAS-STING-related genes risk model provides a new credible risk stratification method to improve the clinical prognostic assessment for breast cancer.<\/jats:p>","DOI":"10.3389\/fgene.2023.1121018","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:59:46Z","timestamp":1679893186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a risk model to predict prognosis in breast cancer based on cGAS-STING-related genes"],"prefix":"10.3389","volume":"14","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/bioinformatics\/btu660","article-title":"Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data","volume":"31","author":"Bastien","year":"2015","journal-title":"Bioinformatics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"bav006","DOI":"10.1093\/database\/bav006","article-title":"PathCards: Multi-source consolidation of human biological pathways","volume":"2015","author":"Belinky","year":"2015","journal-title":"Database (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/genes13060960","article-title":"The history of early breast cancer treatment","volume":"13","author":"Ben-Dror","year":"2022","journal-title":"Genes (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6290261","DOI":"10.1155\/2021\/6290261","article-title":"Identification of a tumor microenvironment-related gene signature indicative of disease prognosis and treatment response in colon cancer","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"984273","DOI":"10.3389\/fgene.2022.984273","article-title":"A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration","volume":"13","author":"Chi","year":"","journal-title":"Front. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.3390\/cells11213436","article-title":"Cuprotosis programmed-cell-death-related lncRNA signature predicts prognosis and immune landscape in PAAD patients","volume":"11","author":"Chi","year":"","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1056310","DOI":"10.3389\/fendo.2022.1056310","article-title":"Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma","volume":"13","author":"Chi","year":"","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1018685","DOI":"10.3389\/fimmu.2022.1018685","article-title":"Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC","volume":"13","author":"Chi","year":"","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: Recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10147-017-1155-5","article-title":"Brachytherapy in the treatment of breast cancer","volume":"22","author":"Deng","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"Denkert","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coi.2017.11.004","article-title":"Cytosolic sensing of immuno-stimulatory DNA, the enemy within","volume":"50","author":"Dhanwani","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/cac2.12078","article-title":"Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy","volume":"40","author":"Ding","year":"2020","journal-title":"Cancer Commun. (Lond)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1126\/science.aat1022","article-title":"DNA-induced liquid phase condensation of cGAS activates innate immune signaling","volume":"361","author":"Du","year":"2018","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: Facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gluck","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","article-title":"Compendium of immune signatures identifies conserved and species-specific Biology in response to inflammation","volume":"44","author":"Godec","year":"2016","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/annonc\/mds530","article-title":"Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy","volume":"24","author":"Gonzalez-Angulo","year":"2013","journal-title":"Ann. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccell.2020.11.004","article-title":"MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway","volume":"39","author":"Guan","year":"2021","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman","year":"2018","journal-title":"J. Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1214\/19-aoas1261","article-title":"Oblique random survival forests","volume":"13","author":"Jaeger","year":"2019","journal-title":"Ann. Appl. Stat."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: New pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin-33\/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells","volume":"134","author":"Jovanovic","year":"2014","journal-title":"Int. J. Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"B41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"731798","DOI":"10.3389\/fphar.2021.731798","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform"},{"key":"B49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.2967\/jnumed.115.157834","article-title":"Clinical diagnosis and management of breast cancer","volume":"57","author":"McDonald","year":"2016","journal-title":"J. Nucl. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","article-title":"Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction","volume":"29","author":"Mlecnik","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e2201376119","DOI":"10.1073\/pnas.2201376119","article-title":"IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer","volume":"119","author":"Ong","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41523-022-00471-5","article-title":"STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer","volume":"8","author":"Pantelidou","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12885-019-5442-6","article-title":"Prognostic models for breast cancer: A systematic review","volume":"19","author":"Phung","year":"2019","journal-title":"BMC Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ccell.2021.05.009","article-title":"Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II\/III breast cancer: Results from the adaptively randomized I-SPY2 trial","volume":"39","author":"Pusztai","year":"2021","journal-title":"Cancer Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202603","article-title":"Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma","volume":"40","author":"Qi","year":"2020","journal-title":"Biosci. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"972383","DOI":"10.3389\/fonc.2022.972383","article-title":"CCL5 mediates breast cancer metastasis and prognosis through CCR5\/Treg cells","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B63","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","article-title":"Clinical relevance of host immunity in breast cancer: From TILs to the clinic","volume":"13","author":"Savas","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-20-2116","article-title":"Fibroblast-derived IL33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type 2 immunity","volume":"80","author":"Shani","year":"2020","journal-title":"Cancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J. Stat. Softw."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S1470-2045(19)30823-X","article-title":"CAR T cells: Continuation in a revolution of immunotherapy","volume":"21","author":"Singh","year":"2020","journal-title":"Lancet Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/1755-0998.13720","article-title":"ploidyfrost: Reference-free estimation of ploidy level from whole genome sequencing data based on de Bruijn graphs","volume":"23","author":"Sun","year":"2023","journal-title":"Mol. Ecol. Resour."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: Extending the Cox model","author":"Therneau","year":"2000"},{"key":"B73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/bioinformatics\/btq617","article-title":"Improved performance on high-dimensional survival data by application of Survival-SVM","volume":"27","author":"Van Belle","year":"2011","journal-title":"Bioinformatics"},{"key":"B74","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccell.2018.05.013","article-title":"Cytosolic DNA sensing in organismal tumor control","volume":"34","author":"Vanpouille-Box","year":"2018","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10495-022-01763-8","article-title":"DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients","volume":"27","author":"Vasiyani","year":"2022","journal-title":"Apoptosis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e43653","DOI":"10.7554\/eLife.43653","article-title":"CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors","volume":"8","author":"Walens","year":"2019","journal-title":"Elife"},{"key":"B77","doi-asserted-by":"publisher","first-page":"989286","DOI":"10.3389\/fimmu.2022.989286","article-title":"Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","article-title":"Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies","volume":"40","author":"Wolf","year":"2022","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41388-021-01853-y","article-title":"A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma","volume":"40","author":"Wu","year":"2021","journal-title":"Oncogene"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1096587","DOI":"10.3389\/fimmu.2022.1096587","article-title":"Investigating regulatory patterns of NLRP3 Inflammasome features and association with immune microenvironment in Crohn's disease","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/ijms22041918","article-title":"Stromal CCL5 promotes breast cancer progression by interacting with CCR3 in tumor cells","volume":"22","author":"Yamaguchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e002115","DOI":"10.1136\/jitc-2020-002115","article-title":"MUC1-C integrates activation of the IFN-gamma pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer","volume":"9","author":"Yamashita","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/21655979.2021.1911557","article-title":"Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Bioengineered"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e2207280119","DOI":"10.1073\/pnas.2207280119","article-title":"Endocytosis triggers V-ATPase-SYK-mediated priming of cGAS activation and innate immune response","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2385","DOI":"10.1002\/rmv.2385","article-title":"Safety and immunogenicity of zika virus vaccine: A systematic review of clinical trials","volume":"33","author":"Yeasmin","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/15384101.2022.2029996","article-title":"STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-beta signalling pathway","volume":"21","author":"Yin","year":"2022","journal-title":"Cell Cycle"},{"key":"B88","doi-asserted-by":"publisher","first-page":"8446857","DOI":"10.1155\/2022\/8446857","article-title":"HSPA8 is a new biomarker of triple negative breast cancer related to prognosis and immune infiltration","volume":"2022","author":"Ying","year":"2022","journal-title":"Dis. Markers"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/bib\/bby073","article-title":"Breast cancer prognosis signature: Linking risk stratification to disease subtypes","volume":"20","author":"Yu","year":"2019","journal-title":"Brief. Bioinform"},{"key":"B92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/brainsci12101349","article-title":"A bioinformatics-based analysis of an anoikis-related gene signature predicts the prognosis of patients with low-grade gliomas","volume":"12","author":"Zhao","year":"2022","journal-title":"Brain Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2020.11.049","article-title":"Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer","volume":"500","author":"Zhou","year":"2021","journal-title":"Cancer Lett."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1121018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:59:51Z","timestamp":1679893191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1121018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":95,"alternative-id":["10.3389\/fgene.2023.1121018"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1121018","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"article-number":"1121018"}}